Related Experiment Video
Updated: Jan 28, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Ambra1 inhibits paclitaxel-induced apoptosis in breast cancer cells by modulating the Bim/mitochondrial pathway
1Department of Medical Oncology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, China.
Abstract:
Cancer cells often evade apoptosis induced by anti-cancer drugs, which reduces the efficacy of the drugs. Autophagy/Beclin 1 regulator 1 (Ambra1) is a crucial proautophagic protein. It also plays an important role in the execution of apoptosis. However, the mechanism by which Ambra1 regulates apoptosis has not been fully clarified. Moreover, whether Ambra1 participates in the regulation of paclitaxel-induced apoptosis in breast cancer cells is not clear. Here, we show that Ambra1 inhibits paclitaxel-induced apoptosis in breast cancer cells. Moreover, Bim and mitochondria are key effectors of Ambra1 in this process. Thus, Ambra1 is a protein that makes breast cancer cells resistant to apoptosis by modulating the Bim/mitochondrial pathway. Therefore, Ambra1 may be a potential target for the treatment of breast cancer.
Insights
Autophagy/Beclin 1 regulator 1 (Ambra1) hinders apoptosis in breast cancer cells treated with paclitaxel. Ambra1 targets the Bim/mitochondrial pathway, suggesting it as a potential therapeutic target for breast cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cancer cells frequently resist apoptosis, limiting anti-cancer drug effectiveness.
- Autophagy/Beclin 1 regulator 1 (Ambra1) is a key protein in autophagy and apoptosis.
- The precise role of Ambra1 in apoptosis regulation remains unclear.
Purpose of the Study:
- To investigate Ambra1's role in paclitaxel-induced apoptosis in breast cancer cells.
- To elucidate the molecular mechanisms by which Ambra1 influences apoptosis.
Main Methods:
- Cell culture of breast cancer cell lines.
- Apoptosis assays following paclitaxel treatment.
- Western blotting to analyze protein expression (Ambra1, Bim).
- Mitochondrial function assessment.
Main Results:
- Ambra1 significantly inhibits paclitaxel-induced apoptosis in breast cancer cells.
- Ambra1's inhibitory effect is mediated through the modulation of Bim expression.
- Mitochondria are identified as crucial downstream effectors in the Ambra1-mediated pathway.
Conclusions:
- Ambra1 confers resistance to paclitaxel-induced apoptosis in breast cancer by regulating the Bim/mitochondrial pathway.
- Ambra1 represents a potential therapeutic target for overcoming drug resistance in breast cancer treatment.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Feedback Inhibition
Apoptosis
Animal Mitochondrial Genetics
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Mechanisms of Retrovirus-induced Cancers
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...